- Protocol Short Name and Number: SWOG S#0805 / BMT CTN0805 ALL
- Protocol Long Name: Phase II Study Of Combination Of Hyper-CVAD And Dasatinib With Or Without Allogeneic Stem Cell Transplant In Patients With Philadelphia (Ph) Chromosome Positive and/or Bcr-Abl Positive Acute Lymphoblastic Leukemia (ALL) (A BMT Study)
- Protocol (PDF)
- Key Personnel
- BMT CTN # 0805 Protocol Chair: Farhad Ravandi, MD
- BMT CTN # 0805 Protocol Chair: David Porter, MD
- Keywords: SWOG, S0805, Hyper-CVAD, Sadatinib, Acute Lymphocytic Leukemia, ALL, Leukemia, Allo Transplant, Allogeneic Transplant, Allo, Unrelated, Unrelated Donor
This study was closed to new patient accrual on October 1, 2013.